3B Blackbio Dx Limited

3B Blackbio Dx Limited (3BBLACKBIO) is a micro-cap Healthcare company valued at ₹1,238 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move

3B Blackbio Dx Limited last traded at ₹1,457.9, modestly down 0.63% on the day.

Recent developments

On 2026-09-22, the company announced a dividend of ₹5.00 per share, effective from that date. Promoter holding remained at 40.95% as of 2026-06-30, while foreign institutional holding decreased by 0.07 percentage points and domestic institutional holding increased by 0.17 percentage points in the quarter.

Financial performance

The company's business has grown significantly, with annual revenue rising 47.9% and net profit increasing 25.0% year-over-year. However, the latest quarter shows a sharp decline in net profit, which fell 29.0% compared to the same quarter a year earlier, despite revenue rising 50.7%.

Valuation multiples

The stock trades at 21.4 times earnings, a discount to the Healthcare median of 32.0, 3.19 times book value. It yields 0.3%.

Things to watch

The company's net profit margin has narrowed by 7.7 percentage points to 42.3%, and the latest quarter's net profit dropped 29.0% compared to the same quarter a year earlier. The stock is 5.4% below its 52-week high, and the five-year profit growth rate has declined by 12.1% annually.

Where it stands

The company has shown strong revenue growth over the past three years, but recent results indicate a slowdown in profitability. The stock is trading below its 52-week high, and the net profit margin has declined. The most significant movement is the drop in net profit for the latest quarter.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.